1. Wang, Wei, Zhang, Rui, Feng, Ning, Zhang, Longzhen, Liu, Nianli. 2022. Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma. In Journal of clinical and translational hepatology, 11, 369-381. doi:10.14218/JCTH.2022.00166. https://pubmed.ncbi.nlm.nih.gov/36643033/
2. Liu, Zijian, Zhu, Fubin, Zhang, Pu, He, Qingliu, Xiao, Jianghong. 2022. Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation. In Frontiers in genetics, 13, 1074981. doi:10.3389/fgene.2022.1074981. https://pubmed.ncbi.nlm.nih.gov/36506302/
3. Liu, Siyu, Wu, Bing, Li, Xiaomin, Wu, Wen, Ai, Songtao. 2021. Construction and Validation of a Potent Epigenetic Modification-Related Prognostic Signature for Osteosarcoma Patients. In Journal of oncology, 2021, 2719172. doi:10.1155/2021/2719172. https://pubmed.ncbi.nlm.nih.gov/34853590/
4. Zhang, Jian, Miao, Xinxin, Wu, Tianlong, Jia, Jingyu, Cheng, Xigao. 2021. Development and Validation of Ten-RNA Binding Protein Signature Predicts Overall Survival in Osteosarcoma. In Frontiers in molecular biosciences, 8, 751842. doi:10.3389/fmolb.2021.751842. https://pubmed.ncbi.nlm.nih.gov/34926575/
智鼠故事 
